This inventor holds 10 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents. Top assignees: Mallinckrodt, Inc., Curium US LLC. Active years: 2009-2019.
Location History:
- St. Louis, MO (US) (2009 - 2015)
- St. Charles, MO (US) (2019)
Company Filing History:
Years Active: 2009-2019
Title: The Innovations of Andrew D. Speth
Introduction
Andrew D. Speth is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of radionuclide generator technology. With a total of 10 patents to his name, Speth has demonstrated a commitment to advancing medical and scientific applications through his innovative designs.
Latest Patents
Among his latest patents is a system and method for sterilizing sealed radionuclide generator column assemblies. This invention involves a column assembly that includes a column with an interior containing a retaining media and a parent radionuclide. The method ensures that fluid communication with the column interior is prevented by sealing the inlet and outlet ports, allowing for the sterilization of the sealed column assembly. Another significant patent is the self-aligning radioisotope elution system and method. This system features a radioisotope generator equipped with an alignment structure that interfaces with a complementary alignment structure of an auxiliary radiation shield assembly.
Career Highlights
Throughout his career, Andrew D. Speth has worked with prominent companies in the industry, including Mallinckrodt, Inc. and Curium US LLC. His work has been instrumental in developing technologies that enhance the safety and efficiency of radionuclide applications.
Collaborations
Speth has collaborated with notable colleagues such as Duane L. Horton and Kevin Robert Martz. These partnerships have contributed to the successful development of his innovative technologies.
Conclusion
Andrew D. Speth's contributions to the field of radionuclide technology are significant and impactful. His innovative patents and collaborations reflect his dedication to advancing medical science.

